Table 2.

HIV Testing at a multi-disease community health campaign (CHC) by randomized trial group: incentive type and cost.

Incentive Type	N	Tested for HIV	%	p-value	HIV-positive, among tested	%	p-value	CD4+ cells/μL (IQR)
Gain-framed Incentive	861	638	74%	Ref	60	9.4%	Ref	519 (386–661)
Loss-framed Incentive	833	638	77%	0.235a	37	5.8%	0.015a	393 (279–519)
Lottery Incentive	833	648	78%	0.076a	50	7.7%	0.279a	446 (300–647)
Low-cost Incentive (~$US1)	1,250	943	75%	Ref	78	8.3%	Ref	446 (332–625)
High-cost Incentive (~$US5)	1,277	981	77%	0.416b	69	7.0%	0.307	444 (322–664)

^aCompared to gain-framed;

^bCompared to low-cost incentives

IQR=Interquartile range